Raymond Chinn is an Infectious Disease physician affiliated with Health and Human Services Agency. OpenAlex indexes 34 publications with 1,120 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- La Jolla Pharmaceutical CompanyProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor52.2%Descovy100%Part D<11 patientsHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor47.8%Tivicay100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Multisociety guidance for sterilization and high-level disinfection
Infection Control and Hospital Epidemiology
2025 - Multisociety guidance for sterilization and high-level disinfection – CORRIGENDUM
Infection Control and Hospital Epidemiology
2025 - Challenges of a Contact Investigation of Healthcare Personnel Exposed to Mycobacterium tuberculosis Contaminated Bone Allografts, 2023
Antimicrobial Stewardship & Healthcare Epidemiology
2025 - Burkholderia multivorans Infections Associated with Use of Ice and Water from Ice Machines for Patient Care Activities ― Four Hospitals, California and Colorado, 2020–2024
MMWR Morbidity and Mortality Weekly Report
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Rebecca Ferrini, MD
Health and Human Services Agency
Wilma Wooten, MD
Health and Human Services Agency
Andrea Polesky, MD
Health and Human Services Agency
Sayone Thihalolipavan, MD, MPH
Health and Human Services Agency
Thomas Walsh, MD
Cornell University
Douglas Richman, MD
University of California San Diego
Henry Masur, MD
National Institutes of Health
Vance Fowler, MD
Duke University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”